Catasus et al. (2008) investigated the clinicopathological impact of PIK3CA mutations and their relationship to other common genetic alterations in a larger series of endometrial adenocarcinomas [14]. The gene discussed is PIK3CA; the disease is endometrium adenocarcinoma.